What are the major opportunities in the quit smoking drugs market? What are the strategies for the quit smoking drugs market?

For detailed insights on the major opportunities and strategies in the quit smoking drugs market, Read More

How does the quit smoking drugs market relate to the overall economy and other similar markets?

For detailed insights on quit smoking drugs market's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the quit smoking drugs market growth? SWOT analysis of the quit smoking drugs market.

For detailed insights on the key dynamics influencing the quit smoking drugs market growth and SWOT analysis of the quit smoking drugs industry, Read More

Quit Smoking Drugs Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Quit Smoking Drugs Market Report 2026

Name: Quit Smoking Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Product (Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets), By Drug (Varenicline (Chantix), Bupropion (Zyban), Other Drugs), By Distribution (Drug Store, Online Pharmacies, Retail Pharmacies) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Quit Smoking Drugs Market Overview

• Quit Smoking Drugs market size has reached to $44.23 billion in 2025

• Expected to grow to $90.73 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%

• Growth Driver: Rising Addiction Linked To Smoking Fuels Growth In Quit-Smoking Drug Market

• Market Trend: Medicated Products To Address The Unacceptably High Death Burden

• North America was the largest region in 2025.

What Is Covered Under Quit Smoking Drugs Market?

Quit smoking drugs are special drugs that individuals use in quitting smoking and that decrease craving and other nicotine withdrawal symptoms. It is used to deliver nicotine in an alternate form, such as chewing gum or patches, for a brief period, which lessens the withdrawal symptoms from nicotine and the urge to smoke.

The major products of quit-smoking drugs are drug therapy, electronic cigarettes, nicotine inhalers, nicotine replacement therapies, and nicotine sublingual tablets. Drug therapy refers to the administration of drugs to treat or prevent disease. Drugs such as Varenicline (Chantix), Bupropion (Zyban), and others are available in drug stores, online pharmacies, and retail pharmacies.

Quit Smoking Drugs Market Global Report 2026 Market Report bar graph

What Is The Quit Smoking Drugs Market Size and Share 2026?

The quit smoking drugs market size has grown rapidly in recent years. It will grow from $44.23 billion in 2025 to $50.94 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increasing awareness of smoking hazards, rising prevalence of smoking-related diseases, availability of nicotine replacement therapies, government anti-smoking campaigns, growth of pharmaceutical manufacturing in emerging markets.

What Is The Quit Smoking Drugs Market Growth Forecast?

The quit smoking drugs market size is expected to see rapid growth in the next few years. It will grow to $90.73 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to advancement in digital health solutions, rising adoption of personalized medicine, integration of ai in treatment monitoring, expansion of telemedicine services, growth of wearable health monitoring devices. Major trends in the forecast period include personalized nicotine replacement therapies, mobile health (mhealth) & smoking cessation apps, telemedicine-driven prescription support, behavioral therapy integration with drug therapy, wearable devices for monitoring cravings.

Book your 30 minutes free consultation with our research experts

Global Quit Smoking Drugs Market Segmentation

1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets

2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs

3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies

Subsegments:

1) By Drug Therapy: Bupropion (Zyban), Varenicline (Chantix)

2) By E-Cigarettes: Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems

3) By Nicotine Inhalers: Prescription Inhalers, Over-The-Counter Inhalers

4) By Nicotine Replacement Therapies (NRT): Nicotine Patches, Nicotine Gum, Nicotine Lozenges

5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets

What Is The Driver Of The Quit Smoking Drugs Market?

The growing prevalence of smoking addiction is expected to propel the growth of the quit-smoking drug market going forward. Smoking is the practice of inhaling and exhaling burning plant material vapors such as marijuana and hashish, tobacco, and others. Quit smoking drugs are used to reduce the urge to smoke by hampering the craving for tobacco in an individual, where they are used as prescription medications to control nicotine withdrawal symptoms to aid in quitting smoking effectively. For instance, in November 2025, according to the OECD (Organisation for Economic Co-operation and Development), a France-based intergovernmental international organization, 14.8% of people aged 15 and over smoked daily in 2023. The proportion of daily smokers was highest in Türkiye, Hungary, and Greece, as well as in accession/partner countries Indonesia, Bulgaria, and China, where at least one in four people smoked daily. On average, 18.5% of men smoked daily in 2023 compared to 11.4% of women. Therefore, the growing prevalence of smoking addiction is driving the growth of the quit-smoking drug market.

Key Players In The Global Quit Smoking Drugs Market

Major companies operating in the quit smoking drugs market are 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, BioCorRx Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Hikma Pharmaceuticals PLC, IntelGenx Technologies Corp., Innovus Pharmaceuticals Inc., Gilla Inc., Rusan Pharma Ltd., Novartis AG

Global Quit Smoking Drugs Market Trends and Insights

Major companies operating in the quit smoking drugs market are focusing on the development of new formulations and delivery methods, such as generic tablets, to expand market leadership across regions and gain a competitive edge. Generic varenicline tablets are non-branded versions of the medication containing varenicline tartrate, which are bioequivalent to the original branded product and used for smoking cessation therapy. For instance, in January 2024, Lupin Limited, an India-based pharmaceutical company, launched new Varenicline tablets in the United States, available in 0.5 mg and 1 mg strengths. These tablets are the generic versions of Chantix tablets (0.5 mg and 1 mg) from PF Prism C.V. and are used to assist in smoking cessation treatment. As a partial agonist of the nicotinic acetylcholine receptor, varenicline works by stimulating the release of dopamine, which can alleviate withdrawal symptoms and cravings associated with nicotine addiction. This dual mechanism allows it to reduce the pleasurable effects of smoking while providing some stimulation to minimize withdrawal effects.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Quit Smoking Drugs Market?

In September 2024, Dr. Reddy's Laboratories, an India-based pharmaceutical company, acquired the nicotine replacement therapy business from Haleon plc for $680 million (£500 million). The aim of the acquisition is to strengthen Dr. Reddy's position in the global consumer healthcare market, particularly by enhancing its over-the-counter (OTC) offerings and expanding its presence in key international markets outside the United States. Haleon plc is a UK-based consumer health company that specializes in nicotine addiction drugs.

Regional Insights

North America was the largest region in the quit smoking drugs market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Quit Smoking Drugs Market?

The quit-smoking drugs market consists of sales of AXS-05, cytisincline, nadolol, and liraglutide. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Quit Smoking Drugs Market Report 2026?

The quit smoking drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the quit smoking drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Quit Smoking Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$50.94 billion
Revenue Forecast In 2035	$90.73 billion
Growth Rate	CAGR of 15.2% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Product, Drug, Distribution
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, BioCorRx Inc., Ennaid Th
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Quit Smoking Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Quit Smoking Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Quit Smoking Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Quit Smoking Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Artificial Intelligence & Autonomous Intelligence

4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Personalized Nicotine Replacement Therapies

4.2.2 Mobile Health (mHealth) & Smoking Cessation Apps

4.2.3 Telemedicine-Driven Prescription Support

4.2.4 Behavioral Therapy Integration with Drug Therapy

4.2.5 Wearable Devices for Monitoring Cravings

5. Quit Smoking Drugs Market Analysis Of End Use Industries

5.1 Adult Smokers

5.2 Healthcare Providers

5.3 Hospitals & Clinics

5.4 Online Health Platforms

5.5 Pharmacies & Drug Stores

6. Quit Smoking Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Quit Smoking Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Quit Smoking Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Quit Smoking Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Quit Smoking Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Quit Smoking Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Quit Smoking Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Quit Smoking Drugs Market Segmentation

9.1. Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets

9.2. Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Varenicline (Chantix), Bupropion (Zyban), Other Drugs

9.3. Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drug Store, Online Pharmacies, Retail Pharmacies

9.4. Global Quit Smoking Drugs Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bupropion (Zyban), Varenicline (Chantix)

9.5. Global Quit Smoking Drugs Market, Sub-Segmentation Of E-Cigarettes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems

9.6. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Prescription Inhalers, Over-The-Counter Inhalers

9.7. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Replacement Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Nicotine Patches, Nicotine Gum, Nicotine Lozenges

9.8. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Sublingual Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets

10. Quit Smoking Drugs Market Regional And Country Analysis

10.1. Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Quit Smoking Drugs Market

11.1. Asia-Pacific Quit Smoking Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Quit Smoking Drugs Market

12.1. China Quit Smoking Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Quit Smoking Drugs Market

13.1. India Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Quit Smoking Drugs Market

14.1. Japan Quit Smoking Drugs Market Overview

14.2. Japan Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Quit Smoking Drugs Market

15.1. Australia Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Quit Smoking Drugs Market

16.1. Indonesia Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Quit Smoking Drugs Market

17.1. South Korea Quit Smoking Drugs Market Overview

17.2. South Korea Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Quit Smoking Drugs Market

18.1. Taiwan Quit Smoking Drugs Market Overview

18.2. Taiwan Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Quit Smoking Drugs Market

19.1. South East Asia Quit Smoking Drugs Market Overview

19.2. South East Asia Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Quit Smoking Drugs Market

20.1. Western Europe Quit Smoking Drugs Market Overview

20.2. Western Europe Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Quit Smoking Drugs Market

21.1. UK Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Quit Smoking Drugs Market

22.1. Germany Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Quit Smoking Drugs Market

23.1. France Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Quit Smoking Drugs Market

24.1. Italy Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Quit Smoking Drugs Market

25.1. Spain Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Quit Smoking Drugs Market

26.1. Eastern Europe Quit Smoking Drugs Market Overview

26.2. Eastern Europe Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Quit Smoking Drugs Market

27.1. Russia Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Quit Smoking Drugs Market

28.1. North America Quit Smoking Drugs Market Overview

28.2. North America Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Quit Smoking Drugs Market

29.1. USA Quit Smoking Drugs Market Overview

29.2. USA Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Quit Smoking Drugs Market

30.1. Canada Quit Smoking Drugs Market Overview

30.2. Canada Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Quit Smoking Drugs Market

31.1. South America Quit Smoking Drugs Market Overview

31.2. South America Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Quit Smoking Drugs Market

32.1. Brazil Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Quit Smoking Drugs Market

33.1. Middle East Quit Smoking Drugs Market Overview

33.2. Middle East Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Quit Smoking Drugs Market

34.1. Africa Quit Smoking Drugs Market Overview

34.2. Africa Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Quit Smoking Drugs Market Regulatory and Investment Landscape

36. Quit Smoking Drugs Market Competitive Landscape And Company Profiles

36.1. Quit Smoking Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Quit Smoking Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Quit Smoking Drugs Market Company Profiles

36.3.1. 22nd Century Group Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Cipla Limited Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. GSK Plc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

37. Quit Smoking Drugs Market Other Major And Innovative Companies

NJOY LLC, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, BioCorRx Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Hikma Pharmaceuticals PLC, IntelGenx Technologies Corp., Innovus Pharmaceuticals Inc., Gilla Inc., Rusan Pharma Ltd., Novartis AG

38. Global Quit Smoking Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Quit Smoking Drugs Market

40. Quit Smoking Drugs Market High Potential Countries, Segments and Strategies

40.1 Quit Smoking Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Quit Smoking Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Quit Smoking Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Quit Smoking Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global Quit Smoking Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Quit Smoking Drugs Market, Supply Chain Analysis

Table 4: Global Quit Smoking Drugs Market, Major Raw Material Providers

Table 5: Global Quit Smoking Drugs Market, Major Resource Providers

Table 6: Global Quit Smoking Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global Quit Smoking Drugs Market, Major Distributors And Channel Partners

Table 8: Global Quit Smoking Drugs Market, Key Technologies & Future Trends

Table 9: Global Quit Smoking Drugs Market, Major Trends

Table 10: Global Quit Smoking Drugs Market, Major End Users

Table 11: Global Quit Smoking Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Quit Smoking Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Quit Smoking Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Quit Smoking Drugs Market - TAM, US$ Billion, 2025

Table 15: Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Quit Smoking Drugs Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Quit Smoking Drugs Market, Sub-Segmentation Of E-Cigarettes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Replacement Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Sublingual Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Quit Smoking Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Quit Smoking Drugs Market - Company Scoring Matrix

Table 99: 22nd Century Group Financial Performance

Table 100: Cipla Limited Financial Performance

Table 101: Dr. Reddy's Laboratories Financial Performance

Table 102: GSK Plc. Financial Performance

Table 103: Johnson & Johnson Financial Performance

Table 104: Global Quit Smoking Drugs Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Quit Smoking Drugs Market, Competitive Dashboard

Table 106: Global Quit Smoking Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Quit Smoking Drugs Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Table 108: Global, Quit Smoking Drugs Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030

Table 109: Global, Quit Smoking Drugs Market Size Gain ($ Billion), Segmentation By Distribution, 2025 – 2030

List Of Figures

Figure 1: Global Quit Smoking Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global Quit Smoking Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Quit Smoking Drugs Market, Supply Chain Analysis

Figure 4: Global Quit Smoking Drugs Market, Major Raw Material Providers

Figure 5: Global Quit Smoking Drugs Market, Major Resource Providers

Figure 6: Global Quit Smoking Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global Quit Smoking Drugs Market, Major Distributors And Channel Partners

Figure 8: Global Quit Smoking Drugs Market, Key Technologies & Future Trends

Figure 9: Global Quit Smoking Drugs Market, Major Trends

Figure 10: Global Quit Smoking Drugs Market, Major End Users

Figure 11: Global Quit Smoking Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Quit Smoking Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Quit Smoking Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Quit Smoking Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Quit Smoking Drugs Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Quit Smoking Drugs Market, Sub-Segmentation Of E-Cigarettes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Replacement Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Sublingual Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Quit Smoking Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Quit Smoking Drugs Market - Company Scoring Matrix

Figure 99: 22nd Century Group Financial Performance

Figure 100: Cipla Limited Financial Performance

Figure 101: Dr. Reddy's Laboratories Financial Performance

Figure 102: GSK Plc. Financial Performance

Figure 103: Johnson & Johnson Financial Performance

Figure 104: Global Quit Smoking Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Quit Smoking Drugs Market, Competitive Dashboard

Figure 106: Global Quit Smoking Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Quit Smoking Drugs Market Size Gain ($ Billion), Segmentation By Product, 2025 – 2030

Figure 108: Global, Quit Smoking Drugs Market Size Gain ($ Billion), Segmentation By Drug, 2025 – 2030

Figure 109: Global, Quit Smoking Drugs Market Size Gain ($ Billion), Segmentation By Distribution, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Oral Transmucosal Drugs Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Oral Transmucosal Drugs Market Landscape: Innovative Preservative-Free Lubricant Eye Drops For Rapid Relief And Lasting Hydration

Top Trends Driving Innovation and Change in the Over The Counter (OTC) Drugs Market: Advancements In Over-The-Counter Nasal Sprays Transforming The Over-The-Counter Drug Market

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Nicotine Addiction Treatment Market Report 2026 - Global Outlook – By Type (Pharmacological, Therapies, Other Types ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By End-User (Generati...

E-Cigarettes Market Report 2026 - Global Outlook – By Product Type ( Disposable, Rechargeable, Modular ), By Composition Used ( Tobacco, Flavors, Nicotine-free ), By Distribution Channel ( Specialist E-Cig Shops, Online,...

Nicotine Addiction Treatment Market Report 2026 - Global Outlook – By Type (Pharmacological, Therapies, Other Types ), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy ), By End-User (Generati...

Hot Tobacco Market Report 2026 - Global Outlook – By Product (HNB Tobacco Devices, Direct/Indirect Heating HNB Tobacco, Infused/Hybrid HNB Tobacco Devices, HNB Tobacco Consumables, HNB Tobacco Sticks, HNB Tobacco Capsule...

Nicotine Replacement Therapy Market Report 2026 - Global Outlook – By Product Type (Patch, Gum, Lozenge, Inhaler, Spray, Other Products), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By ...

Smokeless Tobacco Market Report 2026 - Global Outlook – By Type (Chewing Tobacco, Dipping Tobacco, Dissolvable Tobacco, Snuff, Other Types), By Form (Moist, Dry), By Route (Oral, Nasal), By Distribution Channel (Convenie...

Frequently Asked Questions

How big is the Quit Smoking Drugs Market?

The Quit Smoking Drugs market was valued at $44.23 billion in 2025, increased to $50.94 billion in 2026, and is projected to reach $90.73 billion by 2030. request a sample here

What is the Quit Smoking Drugs market growth?

The global Quit Smoking Drugs market is expected to grow at a CAGR of 15.5% from 2026 to 2035 to reach $90.73 billion by 2035. request a sample here

Who are the key players in Quit Smoking Drugs market?

Some Key Players in the Quit Smoking Drugs market Include, 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, BioCorRx Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Hikma Pharmaceuticals PLC, IntelGenx Technologies Corp., Innovus Pharmaceuticals Inc., Gilla Inc., Rusan Pharma Ltd., Novartis AG . request a sample here

What is the anticipated growth trend for the Quit Smoking Drugs market?

Major trend in this market includes: Medicated Products To Address The Unacceptably High Death Burden. For further insights on this market. request a sample here

Which region has the most growth potential in the Quit Smoking Drugs market?

North America was the largest region in the quit smoking drugs market in 2025. The regions covered in the quit smoking drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Quit Smoking Drugs Market Report 2026 market?

Major companies operating in the Quit Smoking Drugs Market Report 2026 market are Major companies operating in the quit smoking drugs market are 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Perrigo request a sample here.

Book your 30 minutes free consultation with our research experts

Contact Us